Revenue Up 14% to 425.1 Billion Won

Hugel achieved its highest-ever performance last year, with operating profit rising 21% compared to the previous year.


Hugel Co., Ltd. posted, on a consolidated basis, provisional figures for last year of 425.1 billion won in revenue, 201.6 billion won in operating profit, and 144.0 billion won in net profit. These are record-high results, representing year-on-year increases of 14%, 21.3%, and 0.6%, respectively.

Hugel Posts Record-High 201.6 Billion Won Operating Profit in 2024, Up 21% Year-on-Year View original image

Last year’s performance was driven by strong global sales of the botulinum toxin product Botulax (export name LetibotulinumtoxinA, brand name Lettybo) and the HA filler The Chaeum (export name Revolax, etc.) and Vylyse, as well as rapid growth of the cosmetics brands Wellage and Vylyse BR. Annual sales came to 233.8 billion won for toxin products, 129.7 billion won for fillers, and 61.6 billion won for cosmetics and other products.


The combined annual sales of the company’s flagship toxin and filler products increased 10% year-on-year to 363.5 billion won. Of this, overseas sales totaled 268.5 billion won, up 22% from the previous year. In particular, the export share of these two product categories expanded from 66% in 2024 to 74% based on 2025 figures.


By region, growth in North and South America, including the United States and Brazil, was especially notable. Combined toxin and filler sales in this region reached 67.9 billion won, a 105% increase from the previous year. Fourth-quarter sales in the region also surged about 310% year-on-year to 29.2 billion won, showing steep growth.


Hugel plans to further accelerate its global expansion by simultaneously boosting both scale and profitability, focusing on the United States, the world’s largest toxin market. Starting this year, the company will fully implement a hybrid sales model that combines partner distribution with direct sales, aiming to aggressively increase its local market share.


Hugel Global CEO Carrie Strom said, “Based on Hugel’s solid global competitiveness, we have achieved performance in the 400 billion won range in revenue for the first time in our history,” adding, “This year, we plan to further solidify our mid- to long-term global growth foundation, focusing on the global Big Four markets of the United States, China, Europe, and Brazil.”



Meanwhile, Hugel’s fourth-quarter results also showed solid growth on a quarterly basis, with revenue of 119.1 billion won and operating profit of 58.6 billion won, up 21.3% and 26.2%, respectively, from the same period a year earlier.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing